Back to Search Start Over

Increased levels of anti-BSA antibodies in children with Down syndrome.

Authors :
Grace SL
Mortimer GL
Kozhakhmetova A
Leveret J
Newton R
Reimand K
Shield JPH
Uibo R
Williams AJK
Gillespie KM
Source :
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Feb 03; Vol. 14, pp. 1056925. Date of Electronic Publication: 2023 Feb 03 (Print Publication: 2023).
Publication Year :
2023

Abstract

Introduction: Autoimmune diabetes occurs more often in the first 2 years of life in children with Down syndrome (DS) compared with the general population. We previously observed increased frequencies of islet autoantibodies, including insulin autoantibodies (IAA), in children with DS. Assays for IAA using <superscript>125</superscript> I-labelled insulin require competition to overcome cross reactivity with antibodies to the cow's milk protein, bovine serum albumin (BSA). <superscript>125</superscript> I-IAA assay results suggested that levels of antibodies to BSA may also be increased in children with DS. The aim of this study therefore was to determine whether the levels of anti-BSA antibodies differed in children with DS compared with controls.<br />Methods: Samples were available from two populations with DS: one from the UK, (UK DS cohort n=106, 58 male, median age 12.5 years) and one from Estonia (Estonian DS cohort: n=121, 65 male, median age 9.75 years). A UK control population was provided by sex and age-matched healthy siblings of probands participating in the Bart's Oxford (BOX) family study of type 1 diabetes. A competitive-displacement radiobinding assay (RBA) and a Dissociation Enhanced Lanthanide Fluoroimmunoassay (DELFIA) were developed to measure and confirm anti-BSA antibody levels. HLA class II genotype was analysed by PCR using sequence specific primers (PCR-SSP).<br />Results: Overall, levels of anti-BSA antibodies were increased in those with DS compared with controls (p<0.0001) but this was not HLA associated.<br />Conclusion: Increased levels of anti-BSA antibodies may reflect a defect in immune maturation or increased gut permeability in children with DS, increasing their risk of developing autoimmunity.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Grace, Mortimer, Kozhakhmetova, Leveret, Newton, Reimand, Shield, Uibo, Williams and Gillespie.)

Details

Language :
English
ISSN :
1664-2392
Volume :
14
Database :
MEDLINE
Journal :
Frontiers in endocrinology
Publication Type :
Academic Journal
Accession number :
36817608
Full Text :
https://doi.org/10.3389/fendo.2023.1056925